Biotricity Launches Direct-to-Consumer Heart Health Screening Service, HeartSecure, Making Heart Health Services Accessible in Response to the #1 Global Killer, Poising Company to Access the Growing Home Diagnostics Market
Biotricity Inc. (NASDAQ:BTCY), a forerunning Technology-as-a-Service (TaaS) company committed to disrupting the healthcare industry with cutting-edge medical and consumer diagnostic solutions, today announces the highly anticipated launch of its direct-to-consumer heart health screening program, HeartSecure.
Express News | Biotricity Sees Year-End Revenue Growth To Exceed 24% YoY; Loss From Operations To Decrease Over 40% YoY; Margins To Improve Over 10% YoY
Express News | Biotricity Inc: Expects FY Loss From Operations to Decrease by Over 40% YoY
Express News | Biotricity Inc: Expects FY Revenue Growth to Exceed 24% YoY
Biotricity Provides Year-End Guidance With Expectations to Meet Analyst Revenue Target and Beating Loss and Margin Targets
Company expects Loss from Operations to decrease by over 40% YoY and Margin Improvement by over 10% YoYREDWOOD CITY, CA / ACCESSWIRE / June 6, 2024 / Biotricity Inc. (NASDAQ:BTCY), a leading Technolog
Biotricity Preferred Shareholders Show Increased Commitment and Support of the Company by Converting Almost All Preferred A Shares Into Restricted Common Stock
REDWOOD CITY, CA / ACCESSWIRE / June 4, 2024 / Biotricity Inc.] (NASDAQ:BTCY), a leading Technology-as-a-Service (TaaS) company dedicated to disrupting the healthcare industry with cutting-edge medica
Express News | Biotricity Launches Direct-to-Patient Cardiac Screening Service
Biotricity Announces the Upcoming Launch of the First-Ever Direct-to-Patient Cardiac Screening Service, Targeting the $1.05B Home Heart Health Market
REDWOOD CITY, CA / ACCESSWIRE / May 30, 2024 / Biotricity Inc. (NASDAQ:BTCY), a leading Technology-as-a-Service (TaaS) company dedicated to disrupting the healthcare industry with cutting-edge medical
Express News | Biotricity Inc -May Offer & Sell Shares of Common Stock for Offering Price of up to $2.68 Mln From Time to Time
Express News | Biotricity Inc -Entered Into at Market Offering Agreement, Dated March 25, 2022 and an Amendment
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersLucy Scientific Discovery (NASDAQ:LSDI) shares moved upwards by 205.8% to $1.56 during Thursday's regular session. The company's market cap stands at $2.7 million. SINTX Techs (NASDAQ:SINT) sha
Biotricity Files 50M Mixed Securities Shelf
Express News | Biotricity Inc Files for Mixed Shelf of up to $50 Mln - SEC Filing
Biotricity Expands Market Reach to Pulmonary and Neurology Fields Through Latest Partnerships With Two Leading Home-Based Diagnostic Companies
REDWOOD CITY, CA / ACCESSWIRE / April 30, 2024 / Biotricity Inc. (NASDAQ:BTCY), a groundbreaking Technology-as-a-Service (TaaS) company committed to delivering cutting-edge medical and consumer diagno
Express News | Biotricity Announces High Demand For Its LBiotres Pro, a 3-Channel Patch-like ECG, Biotres Pro Is Expected To Raise The Average Subscription Price By Over 32%, Translating To Revenue Increase Of Up To 10% From Sales To Existing Customers Throughout 2025
Biotricity's Path Towards Breakeven Accelerated by Latest Diagnostic Product, Biotres Pro, Garnering Rapid Interest From Existing and New Customers
Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a pioneering Technology-as-a-Service (TaaS) company dedicated to delivering top-of-the-line medical diagnostic and consumer healthcare solutions, announces high demand for its latest breakthrough device, Biotres Pro.
Top Premarket Decliners
Air Industries Group (AIRI) shares slumped nearly 60% Friday premarket, adding to Thursday's slide. Sunshine Biopharma (SBFM) shares were down nearly 18%, extending losses from the previous session. E
Express News | Biotricity Launches Cardiac Monitoring Pilot Program In A Hospital System Comprised Of 9 Hospitals And 10 Clinics
Biotricity Launches Major Cardiac Monitoring Pilot Program in a Hospital System Comprised of 9 Hospitals and 10 Clinics
REDWOOD CITY, CA / ACCESSWIRE / April 18, 2024 / Biotricity Inc. (NASDAQ:BTCY) a leading Technology-as-a-Service (TaaS) company at the forefront of medical diagnostics and consumer healthcare, announc
Biotricity Launches Cardiac Monitoring Pilot Program With Major Hospital Network
REDWOOD CITY, CA / ACCESSWIRE / April 16, 2024 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading Technology-as-a-Service (TaaS) company revolutionizing the medical diagnostic
No Data